Cellectis SA, 102 Avenue Gaston Roussel, 93235 Romainville Cedex, France.
Nucleic Acids Res. 2010 Apr;38(6):2006-18. doi: 10.1093/nar/gkp1171. Epub 2009 Dec 21.
Homing endonucleases have become valuable tools for genome engineering. Their sequence recognition repertoires can be expanded by modifying their specificities or by creating chimeric proteins through domain swapping between two subdomains of different homing endonucleases. Here, we show that these two approaches can be combined to create engineered meganucleases with new specificities. We demonstrate the modularity of the chimeric DmoCre meganuclease previously described, by successfully assembling mutants with locally altered specificities affecting both I-DmoI and I-CreI subdomains in order to create active meganucleases with altered specificities. Moreover these new engineered DmoCre variants appear highly specific and present a low toxicity level, similar to I-SceI, and can induce efficient homologous recombination events in mammalian cells. The DmoCre based meganucleases can therefore offer new possibilities for various genome engineering applications.
归巢内切核酸酶已成为基因组工程的有力工具。通过修饰其特异性或通过在两个不同归巢内切核酸酶的亚结构域之间进行结构域交换来创建嵌合蛋白,可以扩展它们的序列识别库。在这里,我们表明这两种方法可以结合使用,以创建具有新特异性的工程化 meganuclease。我们通过成功组装具有局部改变特异性的突变体来证明以前描述的嵌合 DmoCre meganuclease 的模块化,这些突变体影响 I-DmoI 和 I-CreI 亚结构域,以创建具有改变特异性的活性 meganuclease。此外,这些新的工程化 DmoCre 变体似乎具有高度特异性和低毒性水平,类似于 I-SceI,并且可以在哺乳动物细胞中诱导有效的同源重组事件。因此,基于 DmoCre 的 meganuclease 可以为各种基因组工程应用提供新的可能性。